POINT of DISCUSSION: Without marketing, how can DECN expect
POINT of DISCUSSION: Without marketing, how can DECN expect sales ....revenue...profit?
1 - The TV logs posted on the DECN website are from Jan/Feb 2017 - Are there any commercials currently running? If yes, please send a link?
2 - DECN, PharmaTech, GenStrip, GenUltimate all operate out of the same office?
3 - Google search "diabetic test strips", "cheap diabetic test strips", "third party diabetic test strips", "generic diabetic test strips" and NOTHING related to DECN, Pharmatech nor the Gen lines are returned. Conclusion - no e-marketing, SEM, SEO is being done nor have DECN or Pharmatech been listed by Google Search for relevent content.
4 - Only using the GenStrip or GenUltimate name will return listings (mostly via Amazon) for online retail.
5 - Search of South American ($17.5M) Google local websites lists no Gen branded test strips. Please send a link to any page?
6 - Distributors listed on Pharmatech website either do not have a unique web presence, are resellers on Amazon or operate out of DECN HQ.
This is just the tip of the iceberg. Looks like a lot of smoke yet no fire. RESULTS will stop the bashers, questioners, and disenchanted! 43 days till the 4Q Report ..... let's hope a lot of the "announced efforts and projections" come true!!!!
1
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Investor Sentiment for Dell Technologies Dell Technologies's recent report provides insight into the company's short interest metrics, illustrating a decline of 14.71%. Currently, 17.41 million shares are sold short, which represents about 5.8% of the company's available shares for trading. With an average trading volume indicating it would take 2.78 days to...
Continue Reading
Compass Diversified Investigates Securities Fraud Claims Compass Diversified (NYSE: CODI) is currently facing serious allegations relating to violations in securities laws. An investigation has been initiated to determine the validity of these claims and how they may affect investors. This situation has raised alarms in the investment community as stakeholders seek...
Continue Reading
Understanding the Dow Inc. Class Action Lawsuit Opportunities Investors in Dow Inc. (NYSE: DOW) have a significant opportunity to take action due to a recent class action lawsuit against the company. This legal movement stems from allegations regarding Dow's disclosure practices and possible financial mismanagement. People who purchased or acquired securities within a...
Continue Reading
Overview of the Medical Imaging Reagents Market The medical imaging reagents market is on the verge of significant growth, projected to reach USD 19.31 billion by 2034. This growth, at a compound annual growth rate (CAGR) of 5.1%, reflects the increasing importance of imaging technologies in healthcare. Key Drivers of Market Growth Several factors are driving this...
Continue Reading
GBank Financial Holdings Inc. Welcomes Mike Tyson GBank Financial Holdings Inc. is excited to announce a significant partnership with the legendary Mike Tyson. This strategic collaboration marks a new chapter for GBank, as Tyson steps in as both a strategic investor and promotional partner for the innovative company, BoltBetz. This new partnership aims to revolutionize...
Continue Reading